| Literature DB >> 33099627 |
Monica Anne Wall1, Vasantha Padmanabhan2,3, Ariella Shikanov1,2,4,5.
Abstract
Ovarian tissue cryopreservation and banking provides a fertility preservation option for patients who cannot undergo oocyte retrieval; it is quickly becoming a critical component of assisted reproductive technology programs across the world. While the transplantation of cryopreserved ovarian tissue has resulted in over 130 live births, the field has ample room for technological improvements. Specifically, the functional timeline of grafted tissue and each patient's probability of achieving pregnancy is largely unpredictable due to patient-to-patient variability in ovarian reserve, lack of a reliable method for quantifying follicle numbers within tissue fragments, potential risk of reintroduction of cancer cells harbored in ovarian tissues, and an inability to control follicle activation rates. This review focuses on one of the most common physiological techniques used to study human ovarian tissue transplantation, xenotransplantation of human ovarian tissue to mice and endeavors to inform future studies by discussing the elements of the xenotransplantation model, challenges unique to the use of human ovarian tissue, and novel tissue engineering techniques currently under investigation.Entities:
Keywords: hormonal stimulation; human ovarian tissue xenotransplantation; oncofertility
Mesh:
Year: 2020 PMID: 33099627 PMCID: PMC7671278 DOI: 10.1210/endocr/bqaa194
Source DB: PubMed Journal: Endocrinology ISSN: 0013-7227 Impact factor: 4.736